(Q39414818)

English

Positron emission tomography of 64Cu-DOTA-Rituximab in a transgenic mouse model expressing human CD20 for clinical translation to image NHL.

scientific article published on October 2012

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Positron emission tomography of 64Cu-DOTA-Rituximab in a transgenic mouse model expressing human CD20 for clinical translation to image NHL. (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

positron emission tomography

1 reference

based on heuristic

inferred from title

author name string

Arutselvan Natarajan

1

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Gayatri Gowrishankar

2

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Carsten H Nielsen

3

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Sen Wang

4

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Andrei Iagaru

5

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Michael L Goris

6

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Sanjiv Sam Gambhir

7

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

publication date

1 October 2012

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Molecular Imaging and Biology

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

14

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

608-616

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Positron-emission tomography and assessment of cancer therapy

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0537-8

21 January 2018

High-resolution microPET imaging of carcinoembryonic antigen-positive xenografts by using a copper-64-labeled engineered antibody fragment

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0537-8

21 January 2018

Use of Radiolabeled Antibodies to Carcinoembryonic Antigen for the Detection and Localization of Diverse Cancers by External Photoscanning

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0537-8

21 January 2018

Prolonged in vivo tumour retention of a human diabody targeting the extracellular domain of human HER2/neu

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0537-8

21 January 2018

Monoclonal Antibody Therapy for B-Cell Non-Hodgkin's Lymphoma

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0537-8

21 January 2018

Imaging cancer using PET--the effect of the bifunctional chelator on the biodistribution of a (64)Cu-labeled antibody

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0537-8

21 January 2018

In vitro characterization of (177)Lu-radiolabelled chimeric anti-CD20 monoclonal antibody and a preliminary dosimetry study

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0537-8

21 January 2018

The role of complement in the mechanism of action of rituximab for B-cell lymphoma: implications for therapy

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0537-8

21 January 2018

Mechanisms of killing by anti-CD20 monoclonal antibodies.

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0537-8

21 January 2018

Synthesis and evaluation of novel bifunctional chelating agents based on 1,4,7,10-tetraazacyclododecane-N,N',N",N"'-tetraacetic acid for radiolabeling proteins

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0537-8

21 January 2018

18F-FDOPA: a multiple-target molecule

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0537-8

21 January 2018

A versatile bifunctional chelate for radiolabeling humanized anti-CEA antibody with In-111 and Cu-64 at either thiol or amino groups: PET imaging of CEA-positive tumors with whole antibodies

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0537-8

21 January 2018

Mass spectral analyses of labile DOTA-NHS and heterogeneity determination of DOTA or DM1 conjugated anti-PSMA antibody for prostate cancer therapy

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0537-8

21 January 2018

In vivo evaluation of 177Lu- and 67/64Cu-labeled recombinant fragments of antibody chCE7 for radioimmunotherapy and PET imaging of L1-CAM-positive tumors.

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0537-8

21 January 2018

Targeting of renal carcinoma with 67/64Cu-labeled anti-L1-CAM antibody chCE7: selection of copper ligands and PET imaging.

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0537-8

21 January 2018

Determination of the immunoreactive function of radiolabeled monoclonal antibodies by linear extrapolation to binding at infinite antigen excess

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0537-8

21 January 2018

The remarkable stability of chimeric, sialic acid-derived alpha/delta-peptides in human blood plasma

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0537-8

21 January 2018

microPET-based biodistribution of quantum dots in living mice

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0537-8

21 January 2018

AMIDE: a free software tool for multimodality medical image analysis

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0537-8

21 January 2018

Physical models and dose factors for use in internal dose assessment

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0537-8

21 January 2018

Radiopharmaceuticals in preclinical and clinical development for monitoring of therapy with PET

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0537-8

21 January 2018

Development and characterization of clinical-grade 89Zr-trastuzumab for HER2/neu immunoPET imaging

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0537-8

21 January 2018

Biodistribution of 89Zr-trastuzumab and PET imaging of HER2-positive lesions in patients with metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0537-8

21 January 2018

A comparison of 111In- or 64Cu-DOTA-trastuzumab Fab fragments for imaging subcutaneous HER2-positive tumor xenografts in athymic mice using microSPECT/CT or microPET/CT.

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0537-8

21 January 2018

Healthy animals and animal models of human disease(s) in safety assessment of human pharmaceuticals, including therapeutic antibodies

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0537-8

21 January 2018

The usefulness of (18)F-fluorodeoxyglucose positron emission tomography ((18)F-FDG-PET) and a comparison of (18)F-FDG-pet with (67)gallium scintigraphy in the evaluation of lymphoma: relation to histologic subtypes based on the World Health Organiza

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0537-8

21 January 2018

ImmunoPET imaging of B-cell lymphoma using 124I-anti-CD20 scFv dimers (diabodies).

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0537-8

21 January 2018

Role of fluorine-18 fluoro-deoxyglucose positron emission tomography scan in the evaluation and follow-up of patients with low-grade lymphomas.

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0537-8

21 January 2018

Sulfhydryl-based tumor antigen-carrier protein conjugates stimulate superior antitumor immunity against B cell lymphomas

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0537-8

21 January 2018

Early tumor response to Hsp90 therapy using HER2 PET: comparison with 18F-FDG PET

1 reference

https://pubmed.ncbi.nlm.nih.gov/22231277

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Depletion of B cells in murine lupus: efficacy and resistance

1 reference

https://pubmed.ncbi.nlm.nih.gov/22231277

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of mass of 111In-benzyl-EDTA monoclonal antibody on hepatic uptake and processing in mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/22231277

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Importance of cellular microenvironment and circulatory dynamics in B cell immunotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/22231277

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor uptake and metabolism of copper-67-labeled monoclonal antibody chCE7 in nude mice bearing neuroblastoma xenografts

1 reference

https://pubmed.ncbi.nlm.nih.gov/22231277

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Synthesis, characterization, and evaluation of a novel bifunctional chelating agent for the lead isotopes 203Pb and 212Pb

1 reference

https://pubmed.ncbi.nlm.nih.gov/22231277

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radiolabeled monoclonal anti-tumor antibodies in diagnosis and therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/22231277

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of imaging with (111)In-ibritumomab tiuxetan in the ibritumomab tiuxetan (zevalin) regimen: results from a Zevalin Imaging Registry.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22231277

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radiation dosimetry of 131I-19-iodocholesterol

1 reference

https://pubmed.ncbi.nlm.nih.gov/22231277

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22231277

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

B cell-targeted therapy in autoimmune disease: rationale, mechanisms, and clinical application

1 reference

https://pubmed.ncbi.nlm.nih.gov/22231277

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11307-011-0537-8

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39414818&oldid=2246263946"